Pfizer-BioNTech vaccine deliveries could start 'before Christmas'

Pfizer Inc and BioNTech could secure emergency US and European authorization for their Covid-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers said on Wednesday.